← Top stories
Funding and debt● Neutral for Natco Pharma
Natco Pharma ups investment in organ-transplant biotech eGenesis to $16.7 million
The brief
- Natco Pharma will invest another $16.7 million in US-based eGenesis
- The additional investment takes Natco’s total investment in eGenesis to $24.7 million
- The investment increases Natco Pharma’s exposure to a US biotech company